5 Stocks to BUY: Brokerages recommend Eternal, Maruti Suzuki and others with upto 58% upside potential; check full list
5 Stocks to BUY: Benchmark indices trimmed a large part of their intraday gains on Wednesday as rising crude oil prices weighed on sentiment, following stalled US-Iran talks and the UAE’s exit from Organization of the Petroleum Exporting Countries. The Nifty50 still managed to close 0.76 per cent higher at 24,177.65, while the BSE Sensex ended up 0.79 per cent at 77,496.36. Broader markets showed a mixed trend, with the Nifty MidCap index slipping 0.07 per cent, while the Nifty SmallCap index rose 0.65 per cent. Amid the overall positive momentum, brokerages have recommended select stocks with potential upside of up to 58 per cent.
Maruti Suzuki India Share Price Target
 "Maruti Suzuki India Share Price Target")
Maruti Suzuki India Ltd. remains in focus after Deven Choksey maintained a ‘Buy’ rating with a target of Rs 17,315, implying about 30.6 per cent upside. The positive view is backed by strong demand, a pending order book of around 1.9 lakh units, and ongoing capacity expansion at Kharkhoda and Hansalpur. The stock is trading at Rs 13,257, up 2.83 per cent, but still below its 50-day moving average of Rs 13,668.
Eternal Share Price Target
 "Eternal Share Price Target")
Eternal Ltd. reported a steady Q4FY26 performance, with Anand Rathi maintaining a ‘Buy’ rating and a target price of Rs 400, implying an upside of about 57.5 per cent. Growth was driven by strong traction in B2C NOV, which rose around 54 per cent year-on-year, led by sharp expansion in Blinkit (up ~95 per cent YoY) and solid growth in the food delivery segment at nearly 18.8 per cent. The stock was trading at Rs 254.03, up 0.38 per cent.
Sun Pharmaceutical Industries Share Price Target
 "Sun Pharmaceutical Industries Share Price Target")
Sun Pharmaceutical Industries Ltd. is in focus after Motilal Oswal maintained a ‘Buy’ rating with a target price of Rs 2,025, implying an upside of about 13.8 per cent. The brokerage views the proposed acquisition of New Jersey-based Organon as a strategic fit, expected to strengthen Sun Pharma’s portfolio, expand its global reach, and deepen engagement with healthcare professionals. The stock was trading at Rs 1,778.70, up 1.8 per cent. Promoters pledged 0.45 per cent of shares in the last quarter, taking the total pledge to 1.42 per cent of promoter holdings.
Nippon Life India Asset Management Share Price Target
 "Nippon Life India Asset Management Share Price Target")
Nippon Life India Asset Management Ltd. reported a healthy Q4FY26 performance, with Emkay maintaining a ‘Buy’ rating and raising the target price to Rs 1,150, implying an upside of about 11.8 per cent. The company’s mutual fund quarterly average assets under management (QAAUM) stood at Rs 7.25 trillion, up 3 per cent sequentially, while its market share improved by 24 basis points. The stock was trading at Rs 1,028.90, up 0.55 per cent.
Nippon Life India Asset Management Ltd. reported a healthy Q4FY26 performance, with Emkay maintaining a ‘Buy’ rating and raising the target price to Rs 1,150, implying an upside of about 11.8 per cent. The company’s mutual fund quarterly average assets under management (QAAUM) stood at Rs 7.25 trillion, up 3 per cent sequentially, while its market share improved by 24 basis points. The stock was trading at Rs 1,028.90, up 0.55 per cent.
Varun Beverages Share Price Target
 "Varun Beverages Share Price Target")
Varun Beverages Ltd. remains in focus after Emkay maintained a ‘Buy’ rating and raised the target price to Rs 620, implying an upside of about 18.5 per cent. The brokerage cited strong topline performance and a resilient bottom-line compared to peers, with an 11 per cent PAT beat driving a 5–6 per cent upgrade in earnings estimates. The addition of Twizza also contributed to the positive outlook. The stock was trading at Rs 523.10, up 0.88 per cent.
Varun Beverages Ltd. remains in focus after Emkay maintained a ‘Buy’ rating and raised the target price to Rs 620, implying an upside of about 18.5 per cent. The brokerage cited strong topline performance and a resilient bottom-line compared to peers, with an 11 per cent PAT beat driving a 5–6 per cent upgrade in earnings estimates. The addition of Twizza also contributed to the positive outlook. The stock was trading at Rs 523.10, up 0.88 per cent.
Disclaimer
 "Disclaimer")
The information provided is for informational purposes only and should not be construed as investment advice.